Bimekizumab versus Adalimumab in Plaque Psoriasis

Original Article

R.B. Warren, A. Blauvelt, J. Bagel, K.A. Papp, P. Yamauchi, A. Armstrong, R.G. Langley, V. Vanvoorden, D.D. Cuyper, C. Cioffi, L. Peterson, N. Cross, and K. Reich

N Engl J Med 2021;385:130-141

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
07/07/2021
Course expires: 
07/08/2023

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, July 8, 2023 - 11:59pm.